DRG International, Inc. Associates Awarded Certification of Completion in Dangerous Goods Transportation

Mar 17, 2010News

Mountainside, NJ (Spring 2010) – DRG International, Inc. is proud to announce that several of its associates were recently awarded the Certification of Completion by the Unz&CO Multi-Modal Dangerous Goods Transportation Seminar.
DRG International, the multinational specialty clinical diagnostics and medical equipment manufacturer and distributor with operations in over 110 countries, congratulates Robert Beiner, Monika Bouchat, Xi Chen, Sheila Dawson, Mary Lou Della Donne, Quang Giang, Paulina Maciejski, Judy Parry and Gustavo Ruales on this accomplishment.
“DRG International is proud to continue to provide well-regulated product distribution for its customers,” said Dr. Cyril E. Geacintov, President and CEO of DRG International, Inc. “Our employees’ commitment to quality distribution ensures the safety of our consumers as well as a safe working environment for all of us at DRG.”
The seminar included certification in Training and Testing of CFR Title 49, Party 172.704, plus Security Awareness and Specific Requirements of the Air and Water Modes. Primary subject areas for this certification include: enforcement, classification and table use, packaging selection, marking, labeling, documentation, placarding, emergency response, loading, unloading, and differences between domestic and international regulations.

About DRG International
DRG International, Inc. is a leading specialty medical equipment and diagnostics manufacturer with operations in more than 110 countries. Founded in 1970, DRG International provides a complete range of products and services to the diagnostics medical community. DRG International’s global headquarters is based in Mountainside, New Jersey. For more information, please visit www.drg-international.com.

[starbox]

News and Updates

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.